SCHEMBL24729488

SCHEMBL24729488

OCc1cc(Cl)ccc1-n1cnnn1

nearest known ligand 0.56

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
F2 P00734 11/20 0.49
NOTUM Q6P988 4/20 0.49
F11 P03951 1/20 0.44
MASP2 O00187 1/20 0.43
CYP3A4 P08684 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17232504 0.84 F2 (0.49) F2NOTUMF11MASP2CYP3A4
SCHEMBL642471 0.84 F2 (0.49) F2NOTUMF11MASP2CYP3A4
Hydrochloric Acid SCHEMBL641657 0.83 F2 (0.47) F2NOTUMF11MASP2CYP3A4
Hydrochloric Acid SCHEMBL29880447 0.83 F2 (0.47) F2NOTUMF11MASP2CYP3A4
SCHEMBL30711653 0.82 F11 (0.48) F2NOTUMF11MASP2CYP3A4
SCHEMBL27033841 0.82 F11 (0.48) F2NOTUMF11MASP2CYP3A4
SCHEMBL10290444 0.82 F2 (0.46) F2NOTUMF11MASP2CYP3A4
SCHEMBL3004861 0.82 F2 (0.46) F2NOTUMF11MASP2CYP3A4
SCHEMBL30711643 0.81 F2 (0.47) F2NOTUMF11MASP2CYP3A4
SCHEMBL27033847 0.81 F2 (0.47) F2NOTUMF11MASP2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308227-A1 IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN Takeda Pharmaceutical Company Limited (JP) 2024-01-24 EP disclosed
CN-117396473-A Imidazopyridinyl inhibitors of plasma kallikrein 武田药品工业株式会社 2024-01-12 CN disclosed
WO-2022197755-A1 IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 WO disclosed
WO-2022197755-A1 IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 WO disclosed